Biotech 2012
| Series: | |
| Publisher: | Burrill & Company |
| Subject: | Biotechnology industries--United States, Pharmaceutical biotechnology |
| Authors: | G. Steven Burrill |
| Pages: | 333 pages |
| Binding: | Hardcover |
| ISBN: | 9780974320915 |
| Call No: | HD 9999.B48 B615 2012 |
Considered required reading by executives in the life sciences industry, this book is an invaluable, one-stop resource for making sense of today's changing landscape. Innovating in the New Austerity. Provides analysis of the life sciences industry with data, graphs, and industry highlights including new product approvals, advances in technology, and details of financing and M&A transactions. Examines how pharmaceutical companies are reinventing themselves to innovate for less in this era of austerity. Tracks the convergence of wireless, mobile, and Internet technologies transforming the economics and delivery of healthcare worldwide. Explores the impact of graying populations on healthcare around the world and how regenerative therapies may slow or reverse the diseases of aging. Gives a detailed view of the rise of emerging markets and how these economies are moving from being centers of low-cost manufacturing to world class innovation Explains the challenges biofuels developers face in expanding their production to commercial scale. Analyzes the global interplay between business, policy, regulation, and reimbursement Comprehensive, unparalleled coverage of key trends makes Innovating in the New Austerity a critical resource for life sciences professionals.